Serina Therapeutics receives NYSE deficiency notice on equity standards Jan 15, 2026 04:30PM
Serina Therapeutics receives NYSE American compliance notice Jan 15, 2026 04:11PM
Serina Therapeutics secures up to $20 million for Parkinson's drug trial Sep 9, 2025 03:21PM
Serina Therapeutics (SER) halted, news pending Sep 9, 2025 03:12PM
Serina Therapeutics receives FDA support for Parkinson's drug study Aug 25, 2025 04:16PM


Jul 29, 2025 06:45AM Serina Therapeutics advances weekly injectable for tardive dyskinesia
Apr 8, 2025 04:32PM Serina Therapeutics (SER) Secures $5M in Funding to Support Advancement of SER-252
Mar 10, 2025 04:06PM Jones Trading Starts Serina THerapeutics (SER) at Buy, PT $11
Feb 3, 2025 04:30PM Serina Therapeutics (SER) Receives Second $5M Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial
Jan 15, 2025 04:10PM Serina Therapeutics (SER)Announces Sale of UniverXome Subsidiary